Orthofix International | OFIX - Cost Of Sales


Orthofix International reported $66.63M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 37.29M 786K Sep/2025
Artivion USD 42.85M 3.86M Dec/2025
AtriCure USD 31.94M 3.22M Mar/2026
Dexcom USD 441.6M 25.3M Mar/2026
EDAP TMS EUR 7.91M 1.31M Sep/2025
Globus Medical USD 263.59M 26.88M Mar/2026
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 232.7M 17.5M Mar/2026
Integra LifeSciences USD 178.71M 14.73M Mar/2026
J&J USD 8.07B 103M Mar/2026
Medtronic USD 3.8B 195M Mar/2026
Mesa Laboratories USD 21.92M 1.78M Sep/2024
Orthofix International USD 66.63M 6.4M Dec/2025
Smith & Nephew USD 870M 17M Dec/2025
STAAR Surgical USD 24.66M 10.6M Mar/2026
Stryker USD 2.36B 325M Mar/2026
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Teleflex USD 240.84M 20.7M Mar/2026
Veracyte USD 38.49M 794K Mar/2026
Zimmer Biomet Holdings USD 738.3M 231.8M Mar/2026